Addex Therapeutics Ltd
SIX:ADXN
Addex Therapeutics Ltd
Other Current Assets
Addex Therapeutics Ltd
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Addex Therapeutics Ltd
SIX:ADXN
|
Other Current Assets
CHf615.2k
|
CAGR 3-Years
-5%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Other Current Assets
CHf6.4m
|
CAGR 3-Years
17%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Other Current Assets
$11.5m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Other Current Assets
CHf7.7m
|
CAGR 3-Years
42%
|
CAGR 5-Years
35%
|
CAGR 10-Years
4%
|
|
Idorsia Ltd
SIX:IDIA
|
Other Current Assets
CHf29.4m
|
CAGR 3-Years
28%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Other Current Assets
CHf513k
|
CAGR 3-Years
-43%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
See Also
What is Addex Therapeutics Ltd's Other Current Assets?
Other Current Assets
615.2k
CHF
Based on the financial report for Dec 31, 2023, Addex Therapeutics Ltd's Other Current Assets amounts to 615.2k CHF.
What is Addex Therapeutics Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
24%
Over the last year, the Other Current Assets growth was -25%. The average annual Other Current Assets growth rates for Addex Therapeutics Ltd have been -5% over the past three years , 24% over the past five years .